Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Translating genomic research into clinical practice: promise and pitfalls.

Sparano JA, Ostrer H, Kenny PA.

Am Soc Clin Oncol Educ Book. 2013:15-23. doi: 10.1200/EdBook_AM.2013.33.15. Review.

2.

Translational utility of next-generation sequencing.

Ong FS, Lin JC, Das K, Grosu DS, Fan JB.

Genomics. 2013 Sep;102(3):137-9. doi: 10.1016/j.ygeno.2013.04.012. Epub 2013 Apr 28. Review.

3.

What to expect from high throughput genomics in metastatic breast cancers?

Onesti CE, Vicier C, André F.

Breast. 2015 Nov;24 Suppl 2:S19-22. doi: 10.1016/j.breast.2015.07.006. Epub 2015 Aug 1.

PMID:
26238439
4.

[Genomic basis for breast cancer: advances in personalized medicine].

Hidalgo-Miranda A, Jiménez-Sánchez G.

Salud Publica Mex. 2009;51 Suppl 2:s197-207. Review. Spanish.

5.

Initial experience with genomic profiling of heavily pretreated breast cancers.

Staren ED, Braun D, Tan B, Gupta D, Kim S, Kramer K, Markman M.

Ann Surg Oncol. 2014 Oct;21(10):3216-22. doi: 10.1245/s10434-014-3925-x. Epub 2014 Jul 22.

PMID:
25047475
6.

An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.

Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa S, Matsuo Y, Hosoya K, Yamashita M, Taniguchi H, Nosho K, Suzuki H, Yasuda H, Shinomura Y, Itoh F.

World J Gastroenterol. 2014 Apr 14;20(14):3927-37. doi: 10.3748/wjg.v20.i14.3927. Review.

7.

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.

Ross JS, Badve S, Wang K, Sheehan CE, Boguniewicz AB, Otto GA, Yelensky R, Lipson D, Ali S, Morosini D, Chliemlecki J, Elvin JA, Miller VA, Stephens PJ.

Arch Pathol Lab Med. 2015 May;139(5):642-9. doi: 10.5858/arpa.2014-0200-OA.

8.

Genomic profiling of breast cancers.

Curtis C.

Curr Opin Obstet Gynecol. 2015 Feb;27(1):34-9. doi: 10.1097/GCO.0000000000000145. Review.

9.

Genomics-based prognosis and therapeutic prediction in breast cancer.

Jeffrey SS, Lønning PE, Hillner BE.

J Natl Compr Canc Netw. 2005 May;3(3):291-300. Review.

PMID:
16002001
10.
11.

Translating cancer genomes sequencing revolution into surgical oncology practice.

Katsios C, Ziogas DE, Liakakos T, Zoras O, Roukos DH.

J Surg Res. 2012 Apr;173(2):365-9. doi: 10.1016/j.jss.2010.10.038. Epub 2010 Nov 25.

PMID:
21195428
12.

From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.

Kyrochristos ID, Glantzounis GK, Ziogas DE, Gizas I, Schizas D, Lykoudis EG, Felekouras E, Machairas A, Katsios C, Liakakos T, Cho WC, Roukos DH.

Int J Mol Sci. 2017 Jan 18;18(1). pii: E180. doi: 10.3390/ijms18010180. Review.

13.

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.

Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, MacDonald TY, Jarosz M, Lipson D, Tagawa ST, Nanus DM, Stephens PJ, Mosquera JM, Cronin MT, Rubin MA.

Eur Urol. 2013 May;63(5):920-6. doi: 10.1016/j.eururo.2012.08.053. Epub 2012 Sep 5.

14.

Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.

Smith A, Boycott KM, Jarinova O.

Hum Mutat. 2014 Feb;35(2):265-9. doi: 10.1002/humu.22480. Epub 2013 Nov 27.

PMID:
24282140
15.

Genomic subtypes in choosing adjuvant therapy for breast cancer.

Zelnak AB, O'Regan RM.

Oncology (Williston Park). 2013 Mar;27(3):204-10.

16.

Gene-Expression-Based Predictors for Breast Cancer.

Gupta A, Mutebi M, Bardia A.

Ann Surg Oncol. 2015 Oct;22(11):3418-32. doi: 10.1245/s10434-015-4703-0. Epub 2015 Jul 28. Review.

PMID:
26215189
17.

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.

Staaf J, Jönsson G, Ringnér M, Vallon-Christersson J, Grabau D, Arason A, Gunnarsson H, Agnarsson BA, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A.

Breast Cancer Res. 2010;12(3):R25. doi: 10.1186/bcr2568. Epub 2010 May 6.

18.

Ten years of next-generation sequencing technology.

van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C.

Trends Genet. 2014 Sep;30(9):418-26. doi: 10.1016/j.tig.2014.07.001. Epub 2014 Aug 6. Review.

PMID:
25108476
19.

Overview of various techniques/platforms with critical evaluation of each.

Agwa E, Ma PC.

Curr Treat Options Oncol. 2013 Dec;14(4):623-33. doi: 10.1007/s11864-013-0259-z. Review.

PMID:
24243164
20.

Challenges translating breast cancer gene signatures into the clinic.

Weigelt B, Pusztai L, Ashworth A, Reis-Filho JS.

Nat Rev Clin Oncol. 2011 Aug 30;9(1):58-64. doi: 10.1038/nrclinonc.2011.125. Review.

PMID:
21878891

Supplemental Content

Support Center